Search
for

    Did you mean Transient Receptor Potential Channels?
    Glossary Transient Receptor Potential Channels

    ion channels involved in sensory perception and physiological processes

    Transient Receptor Potential (TRP) channels are a group of ion channels located in the cell membrane that play a crucial role in various physiological processes, including sensation and temperature regulation. These channels respond to a wide range of stimuli, such as temperature changes, pH levels, and mechanical stress, and are involved in sensory functions like pain perception and taste.

    Related Terms

    Research

    5 / 1000+ results

    Community Join

    5 / 1000+ results

      community Amplifica: Hope or Cope? A Review of Their Pipeline

       9 upvotes 1 month ago
      Amplifica's AMP-303 showed a modest increase in hair growth, but results were inconsistent and potentially misleading. Hyaluronic acid and osteopontin are being explored for hair growth, with varying effects on different hair types and conditions.

      community Dutasteride absolutely nukes hair DHT

      in Finasteride/Dutasteride  486 upvotes 1 year ago
      Dutasteride significantly reduces DHT levels, potentially more effectively than finasteride, and is used to treat hair loss. Some users report side effects like reduced libido and mood changes, while others experience hair regrowth and increased testosterone.

      community It all feels like a pointless cope

      in Chat  17 upvotes 5 months ago
      The user is frustrated with hair loss despite using finasteride and is considering a hairpiece as a solution. Suggestions include trying a buzz cut, considering dutasteride or oral minoxidil, and addressing potential dietary issues.

      community GT20029 China Phase II Trial For AGA Reached Primary Endpoint

       133 upvotes 2 years ago
      The GT20029 tincture, a topical androgen receptor degrader, showed significant hair growth and good safety in a China Phase II trial for male androgenetic alopecia (AGA), with the 1% dose twice weekly identified as optimal. The company plans to initiate Phase III trials in China and Phase II in the U.S., and the treatment also shows promise for acne.